Cardinal Health Stock News

Cardinal Health stock rose slightly early Tuesday on better-than-expected fiscal fourth-quarter earnings, but sales missed.

U.S. drug distributor Cardinal Health on Tuesday forecast fiscal 2027 profit well above Wall Street expectations after ​topping fourth-quarter profit estimates, driven by sustained demand ‌for specialty drugs.

Cardinal Health reports mixed quarterly performance across its business segments as earnings get a lift from one-time tariff refunds.

Cardinal Health had a mixed fiscal fourth quarter in terms of sales across its two main business lines, but expects revenue to rise in both segments in the new fiscal year.

Fourth quarter revenue increased 6% to $63.7 billion Fourth quarter GAAP 1 diluted EPS increased 70% to $1.70 Excluding a one-time positive impact of $0.31 from the recognition of the IEEPA tariff refund, fourth quarter non-GAAP diluted EPS increased 25% to $2.60, with reported fourth quarter non-GAAP diluted EPS increasing 40% to $2.91 For fiscal year 2026, excluding the IEEPA tariff refund re...

DUBLIN, Ohio,, Aug. 11, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5158 per share, out of the Company's capital surplus. The dividend will be payable on October 15, 2026 to shareholders of record at the close of business on October 1, 2026.

Cardinal Health said on Monday it has agreed to buy AdaptHealth's diabetes health business and ​medical supply provider Strive Medical in separate deals ‌for about $360 million in total, expanding its home care business.